drugset / Trial / NCT04082676

Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients

NCT04082676 ↗

Phase 4 Completed 112 enrolled B.P. Koirala Institute of Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

Doses of intrathecal bupivacaine based on patients either height or height and weight has shown to lower the risk of maternal hypotension with similar quality of anesthesia compared to conventional doses. In clinical practice there is a tendency of reducing the dose of bupivacaine as either low fixed dose or using the doses based on either height and weight or height (0.06mg/cm) alone in parturient with short stature. However, there is lack of evidence regarding the appropriate dose required in this group of patients. Therefore, our aim is to compare the height versus height and weight based intrathecal bupivacaine dose for elective caesarean on maternal haemodynamics in short stature patients.

Timeline

Start
2019-11-30
Primary completion
2021-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — Intrathecal
Comparator Fentanyl Other / unclassified 10 ug Intrathecal

Indications

No indication recorded.